Cisplatin (cddp) triggers cell death of mcf-7 cells following disruption of intracellular calcium ([ca2+]i) homeostasis

Journal of Toxicological Sciences

Volumn 39, Issue 5, 2014, Pages 765-774

  Al Taweel, Nawaf ^a   Varghese, Elizabeth ^a   Florea, Ana Maria ^b   Büsselberg, Dietrich ^a  

^a QATAR FOUNDATION   (Qatar)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Breast cancer; Calcium signaling; Cisplatin; MCF 7; Tumor cell death

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; NIMODIPINE;

APOPTOSIS; ARTICLE; BREAST CANCER; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MTT ASSAY; BREAST TUMOR; CALCIUM SIGNALING; DRUG EFFECTS; FEMALE; HOMEOSTASIS; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELL DEATH; CISPLATIN; FEMALE; HOMEOSTASIS; HUMANS; MCF-7 CELLS; NIMODIPINE;

EID: 84907506936     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.39.765     Document Type: Article

References (29)

1. Biersack, B., Ahmad, A., Sarkar, F.H. and Schobert, R. (2012): Coinage metal complexes against breast cancer. Curr. Med. Chem., 19, 3949-3956.
2. Carafoli, E., Santella, L., Branca, D. and Brini, M. (2001): Generation, control, and processing of cellular calcium signals. Crit. Rev. Biochem. Mol. Biol., 36, 107-260.
3. Cobleigh, M.A. (2011): Other options in the treatment of advanced breast cancer. Semin Oncol., 38, S11-16. doi. 10.1053/j. seminoncol.2011.04.005.
4. Colombo, P.E., Milanezi, F., Weigelt, B. and Reis-Filho, J.S. (2011): Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction. Breast Cancer Res., 13, 212.
5. Dumitrescu, R.G. and Cotarla, I. (2005): Understanding breast cancer risk -- where do we stand in 2005? J. Cell. Mol. Med., 9, 208-221.
6. Eckstein, N. and Haas, B. (2012): [Platinum-based chemotherapy in triple negative breast cancer]. [Article in German] Dtsch. Med. Wochenschr., 137, 333-336. doi: 10.1055/s-0031-1298891.
7. Florea, A.-M. and Büsselberg, D. (2011): Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects. Cancers, 3, 1351-1371. doi:10.3390/ cancers3011351.
8. Florea, A.-M. and Büsselberg, D. (2012): Metals and Breast cancer: Risk factors or Healing agents? J. Toxicol., Special Issue “Metals and disease”, ID 825354, doi:10.1155/2012/825354.
9. Florea, A.-M. and Büsselberg, D. (2013): Breast cancer and possible mechanisms of therapy resistance. Journal of Global and Local Health Science Vol. 2013, 2.
10. i transients induced by trimethyltin chloride in HeLa cells: types and levels of response. Cell Calcium, 37, 251-258.
11. Florea, A.-M. and Busselberg, D. (2006): Occurrence, use and potential toxic effects of metals and metal compounds. Biometals, 19, 419-427.
12. 3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicol. Appl. Pharmacol., 220, 292-301.
13. Florea, A.-M. and Busselberg, D. (2008): Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells. Toxicol. Lett., 179, 34-42.
14. Florea, A.-M. and Busselberg, D. (2009a): Anti-cancer drugs interfere with intracellular calcium signaling. Neurotoxicology, 30, 803-810.
15. Florea, A.-M. and Busselberg, D. (2009b): Metallic compounds (arsenic trioxide and trimethyltin chloride) interact with calcium homeostasis and trigger cell death in “in vitro” systems. Mat.-wiss. u. Werkstofftech., 40, 13-16.
16. i and cytotoxicity. Neurotoxicology, 30, 194-202.
17. Hurley, J., Reis, I.M., Rodgers, S.E., Gomez-Fernandez, C., Wright, J., Leone, J.P., Larrieu, R. and Pegram, M.D. (2013): The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients. Breast Cancer Res. Treat., 138, 783-794. doi: 10.1007/ s10549-013-2497-y.
18. Joensuu, H. and Gligorov, J. (2012): Adjuvant treatments for triple-negative breast cancers. Ann. Oncol., 23, vi40-5.
19. Lipskaia, L. and Lompré, A. M. (2004): Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biol. Cell, 96, 55-68.
20. 2+ transport. Nat. Rev. Cancer, 7, 519-530.
21. Motiani, R.K., Stolwijk, J.A., Newton, R.L., Zhang, X., Trebak, M. (2013): Emerging roles of Orai3 in pathophysiology. Channels (Austin), 7, 392-401.
22. Muscella, A., Calabriso, N., Vetrugno, C., Fanizzi, F.P., De Pascali, S.A., Storelli, C. and Marsigliante, S. (2011): The platinum (II) complex [Pt(O,O’-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells. Biochem. Pharmacol., 81, 91-103. doi: 10.1016/j.bcp.2010.09.012.
23. Normanno, N., Morabito, A., De Luca, A., Piccirillo, M.C., Gallo, M., Maiello, M.R. and Perrone, F. (2009). Target-based therapies in breast cancer: current status and future perspectives. Endocr. Relat. Cancer, 16, 675-702.
24. Prabhakaran, P., Hassiotou, F., Blancafort, P. and Filgueira, L. (2013): Cisplatin induces differentiation of breast cancer cells. Front. Oncol., 3, 134. doi: 10.3389/fonc.2013.00134.
25. Shamseddine, A.I. and Farhat, F.S. (2011): Platinum-based compounds for the treatment of metastatic breast cancer. Chemotherapy, 57, 468-487. doi: 10.1159/000334093.
26. 2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis. Brit. J. Pharmacology, 151, 1176-1186.
27. 2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth. Mol. Cancer, 9, 156. doi: 10.1186/1476-4598-9-156.
28. Van’t Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., Peterse, H.L., van der Kooy, K., Marton, M.J., Witteveen, A.T., Schreiber, G.J., Kerkhoven, R.M., Roberts, C., Linsley, P.S., Bernards, R. and Friend, S.H. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
29. Zhang, W., Couldwell, W.T., Song, H., Takano, T., Lin, J.H. and Nedergaard, M. (2000): Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Res., 60, 5395-5400.